Butterfly Network Announces FDA Clearance of its Next-Generation Handheld Ultrasound System, Butterfly iQ3
08 1월 2024 - 10:05PM
Business Wire
Butterfly iQ3 brings unparalleled image quality and new digital
imaging modes, iQ Slice and iQ Fan, powered by advanced
semiconductor technology for easier, automated image
acquisition
Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital
health company transforming care through the power of portable,
semiconductor-based ultrasound technology and intuitive software,
today announced the FDA clearance of its next-generation handheld
point-of-care ultrasound (POCUS) system, Butterfly iQ3. The new
device is the company’s third iteration of the world’s first
semiconductor-based single-probe, whole-body ultrasound system.
Butterfly iQ3 features a brand-new ergonomic design and will
deliver double the data processing speed for optimized image
resolution, sensitivity and penetration, as well as faster 3D
capabilities to power novel, automated image capture modes: iQ
Slice and iQ Fan.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240108891905/en/
Butterfly iQ3 will feature a brand-new
ergonomic design, to be revealed soon. (Graphic: Business Wire)
“Butterfly iQ3 is the turning point for digital ultrasound.
Butterfly started a revolution in ultrasound when we commercialized
the world’s first fully digital handheld ultrasound in 2018, and
subsequently, iQ+ in 2020,” said Joseph DeVivo, Butterfly Network’s
President, Chief Executive Officer and Chairman. “Over 145,000
customers have since realized the value of our chip-based
ultrasound. With iQ3, the revolution takes full charge. Physicians
across disciplines now rank our overall image quality at least
equal to traditional piezoelectric-based handhelds, and our new
digital capabilities are designed to make ultrasound more
accessible and approachable than ever before.”
DeVivo continued, “I look forward to revealing more about iQ3’s
advanced imaging capabilities this week at the 42nd Annual J.P.
Morgan Healthcare Conference. Stay tuned for more details about the
product and its commercial launch in the United States this
quarter.”
DeVivo and Heather Getz, Butterfly Network’s Chief Financial and
Operations Officer, will present at the J.P. Morgan Healthcare
Conference on Thursday, January 11, 2024 at 9:00 am PT. Access the
live webcast via the Events & Presentations section of
Butterfly’s investor website.
To stay up to date with the latest Butterfly iQ3 launch news,
subscribe here.
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a
digital health company with a mission is to democratize medical
imaging by making high-quality ultrasound affordable, easy-to-use,
globally accessible, and intelligently connected, including for the
4.7 billion people around the world lacking access to ultrasound.
Butterfly created the world's first handheld single-probe,
whole-body ultrasound system using semiconductor technology,
Butterfly iQ. The company has continued to innovate, leveraging the
benefits of Moore’s Law, to launch its second generation Butterfly
iQ+ in 2020, and third generation iQ3 in 2024 – each with increased
processing power and performance enhancements. The disruptive
technology has been recognized by TIME’s Best Inventions, Fast
Company’s World Changing Ideas, CNBC Disruptor 50, and MedTech
Breakthrough Awards, among other accolades. With its proprietary
Ultrasound-on-Chip™ technology, intelligent software, and
educational offerings, Butterfly is paving the way to mass adoption
of ultrasound for earlier detection and remote management of health
conditions around the world. Butterfly devices are commercially
available to trained healthcare practitioners in areas including,
but not limited to, parts of Africa, Asia, Australia, Europe, the
Middle East, North America and South America; to learn more about
available countries, visit:
butterflynetwork.com/choose-your-country.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240108891905/en/
Butterfly Media: Liz Learned Head of Corporate
Communications, Butterfly media@butterflynetwork.com
Butterfly Investors: Heather Getz Chief Financial and
Operations Officers, Butterfly
investors@butterflynetwork.com
or
Neal Nagarajan Sloane & Company (301) 273-5662
nnagaragan@sloanepr.com
Butterfly Network (NYSE:BFLY)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Butterfly Network (NYSE:BFLY)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024